BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. — Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, will debut the new VRNxT™ volume reduction instrument at the upcoming meeting of the Association for Molecular Pathology (AMP) in Baltimore, November 7-9, 2019. Attendees can view the sample preparation instrument, which automates the volume reduction steps in cellular biology workflows, at Booth […]

New ZEISS iCeMS Innovation Core collaborative laboratory opened Jena, Germany, Kyoto, Japan | ZEISS and Kyoto University are intensifying their cooperation and have signed a new strategic research agreement. As part of the agreement, the partners are opening the ZEISS iCeMS Innovation Core – a collaborative laboratory at Kyoto University’s Institute for Integrated Cell-Material Sciences […]

FFPE Tissue Dissociation Kit from Miltenyi Biotec BERGISCH GLADBACH – The FFPE Tissue Dissociation Kit by Miltenyi Biotec enables the effective dissociation of formalin-fixed paraffin-embedded (FFPE) carcinoma samples for the specific enrichment and subsequent molecular analysis of carcinoma tumor cells. This enhances the sensitivity in molecular experiments, such as mutation analysis by next-generation sequencing (NGS). […]

15,000 sq. ft of laboratory and office space at Coldham’s Business Park will enable continued growth and development of the Company’s integrated desktop platform for DNA synthesis CAMBRIDGE, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has moved to Coldham’s Business Park, […]

— Companies Combine Best-in-Class Product Lines for Next-Generation Sequencing — SOUTH SAN FRANCISCO, Calif.–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MGI International Sales Co., Limited (MGI), a subsidiary of global genomics leader BGI Group, today announced a co-marketing agreement […]

Recently, Shenzhen MGI Technology Co., Ltd. and Guangzhou Jiajian Medical Testing Co., Ltd. reached a strategic cooperation agreement in the clinical application direction of single gene genetic disease detection. Jiajian Medical will develop a whole-process overall solution for genetic testing of single-gene genetic diseases based on MGI’s high-throughput sequencing platform to realize the localization, automation […]

Novel Akadeum microbubble technology can be the answer to improved quality and reduced costs across multiple fields of testing. Akadeum Life Sciences, Inc., an Ann Arbor-based biotechnology company, announced today that it has entered into a collaboration with Agilent Technologies, Inc. to work toward a new method of isolating target molecules for detection. Akadeum aims to disrupt […]

LexaGene Announces Closing of CAD$6.64 Million Financing BEVERLY, Mass – (October 29, 2019) –  LexaGene Holdings Inc. (TSX VENTURE: LXG) (OTCQB: LXXGF) (“LexaGene” or the “Company“) is pleased to announce that it has closed its previously announced offering of units (the “Units”) for aggregate gross proceeds of CAD$6.64 million (the “Offering”). The Company issued 12,769,626 Units at a price […]

ArcticZymes AS is pleased to announce the launch of HL-dsDNase Glycerol-free Triton FREE. This launch is a continuing step towards maintaining a completely EU REACH compliant product portfolio after Triton X-100 becomes subject to authorisation in January 2021. The convenient glycerol-free formulation is suitable for lyophilization and automated processes. The new formulation offers the same advantages […]

Leading manufacturer of therapeutic proteins implements Genedata Bioprocess to streamline development and manufacture of biopharmaceuticals Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Octapharma, one of the world’s largest human protein manufacturers, has adopted the Genedata Bioprocess® platform to support the development and manufacturing of therapeutic proteins addressing […]